ClinicalTrials.Veeva

Menu

A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.

A

Albany College of Pharmacy and Health Sciences

Status and phase

Completed
Phase 4

Conditions

Obesity

Treatments

Drug: Orlistat

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.

Enrollment

19 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients preparing for gastric bypass surgery

Exclusion criteria

  • pregnancy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

19 participants in 1 patient group

orlistat 60mg
Experimental group
Description:
Patients assigned to treatment group for up to 6 months of therapy.
Treatment:
Drug: Orlistat

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems